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ABSTRACT 
Long Double-Stranded RNA-Mediated Suppression of PER2 in the SCN Disrupts 
Circadian Locomotor Activity and PER2 Rhythms in the Limbic Forebrain 
Alex M. Gavrila 
Studies with targeted disruption in the Period2 {Perl) gene suggest that the PER2 protein 
participates in the regulation of circadian behavioral rhythms. Moreover, it has been 
shown that direct suppression of PER2 expression in the suprachiasmatic nucleus (SCN) 
with antisense oligonucleotides disrupts photic resetting of the SCN clock. The effect of 
such suppression on behavioral rhythms is unknown. Here double-stranded RNA 
(dsRNA) to Perl was used to transiently suppress PER2 expression in the SCN of adult 
rats. Bilateral infusions of dsRNA into the SCN (6 ^g/side) disrupted circadian wheel 
running activity rhythms for up to 10 days in experimental rats housed in constant 
darkness; whereas, control infusions into the SCN or dorsal infusions of dsRNA to Per2 
had no effect. Relative to controls PER2 suppression in the SCN was evident 12 days 
post-dsRNA infusion; however, maximal suppression was observed at day 3. In addition 
to the suppression of PER2 expression in the SCN, a blunted PER2 rhythm was observed 
in the oval nucleus of the bed nucleus of the stria terminalis, central nucleus of the 
amygdala and dentate gyrus. These results provide direct evidence that the expression of 
PER2 in the SCN is essential for the maintenance of circadian locomotor activity rhythms 
and for the expression of PER2 rhythms in the limbic forebrain in rats. The specificity of 
this effect was validated by demonstrating no difference between cFos expression in any 
of the above areas in control rats and rats treated with dsRNA to Per2. 
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Introduction 
Since the beginning of the Cambrian era, which took place over 500 million years 
ago, the length of the Earth's day has been roughly 24 hours (Tauber, Last, Olive, & 
Kyriacou, 2004). Over the eons, all life forms on Earth, from the smallest prokaryotic 
bacteria to the largest and most complex eukaryotic organisms, have adapted and learned 
to incorporate, to the best of their ability, these daily cycles, or circadian rhythms, which 
are in part a response to daylight or dark. However, environmentally-determined cyclical 
oscillations, such as changes in daylight, temperature, and availability of food, serve 
primarily to refine and adjust physiologically-determined circadian rhythms: In the 
absence of these external cues, the internal rhythms gradually drift out of phase with the 
environment (Yamazaki, et al, 2000). The most evident of these biological rhythms is 
the sleep-wake cycle but there are other equally-important rhythms as well: locomotor-
activity rhythms, daily internal temperature fluctuations, hormone secretion, protein 
synthesis and apoptosis to name a few (Lowrey & Takahashi, 2000). 
Extensive research on rattus norvegicus (Kramer & Poort, 1971), mus musculus 
(Abraham et al., 2006),phodopus sungorus (Antle, LeSauteur, & Silver, 2005; 
Hoffmann, Illnerova, & Vanecek, 1981), arvicanthis ansorgei (Caldelas, Poirel, Sicard, 
Pevet, & Challet, 2003), pan troglodytes (Anestis & Bribiescas, 2004) and homo sapiens 
(Roenneberg, Kumar, & Merrow, 2007) has shown that mammals have a light-
entrainable central pacemaker, located in the suprachiasmatic nucleus (SCN) of the 
hypothalamus. The SCN synchronizes all other circadian oscillators in the brain and the 
periphery which ultimately give rise to behavioral and physiological rhythms (Albrecht, 
in press; Lowrey & Takahashi, 2000). Despite great strides made in the field of circadian 
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research in recent years, the mechanisms through which the SCN entrains subordinate 
oscillators are still poorly understood (Reppert & Weaver, 2002). While measuring the 
rhythmic expression of the clock protein PERIOD2 (PER2), our laboratory has uncovered 
circadian oscillators in the oval nucleus of the bed nucleus of the stria terminalis (BNST-
ov), central nucleus of the amygdala (CEA), basolateral amygdala (BLA) and dentate 
gyrus of the hippocampus (DG; Amir, Lamont, Robinson, & Stewart, 2004; Lamont, 
Robinson, Stewart, & Amir, 2005). 
Studies in mutant mice with targeted disruption in the Per 2 gene suggest that the 
PER2 protein participates in the regulation of circadian behavioral rhythms (Zheng, et al., 
1999). In fact, a number of studies reported complete circadian arrhythmicity in 
Perl/Per 2 double mutant mice (Albrecht, Zhend, Larkin, Sun, & Lee, 2001; Zheng, et 
al., 1999). Mutant studies are limited when one is looking for specific gene silencing 
because the genes of interest are knocked out in virtually all cells of the organism and 
there are numerous developmental confounds. Other studies have used antisense 
oligonucleotides (ODNs) in order to induce temporary Per2 gene silencing in cultured 
SCN neurons (Sugiyama, Yoshioka, & Ikeda, 2004). Wakamatsu and colleagues (2001) 
have transiently suppressed Per2 gene expression in mice by repeatedly performing 
unilateral ODNs microinjections into the lateral ventricle. Although this showed that 
suppression ofPer2 can lead to changes in locomotor activity, evidence for a direct link 
between circadian rhythms in behavior and PER2 expression in the SCN is lacking. 
While ODNs are able to successfully suppress gene expression, their effect is short 
lasting and lacks specificity (Kurreck, 2003). The purpose of this thesis is to elucidate 
the role of PER2 in the SCN by investigating the transient suppression of Per 2 expression 
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in the SCN of adult rats using long double-stranded RNA (dsRNA) to Per2, which is 
longer-lasting and has greater specificity than antisense ODNs. 
The suprachiasmatic nucleus and light entrainment 
In mammals, the focal point of the circadian system is located in the SCN, a small 
bilateral structure of the anterior hypothalamus containing approximately 10,000 neurons 
per hemisphere, which is commonly referred to as the master clock (Reppert & Weaver, 
2002; Stephan & Zucker, 1972; van den Pol, 1980). This is the case because it has been 
shown that lesioning the SCN results in complete loss of circadian rhythms (Abe, 
Kroning, Greer, Critchlow, 1979). Furthermore, it has also been shown that surgically 
transplanted fetal SCN tissue was able to fully restore behavioral rhythms in animals 
whose SCN had previously been lesioned (Ralph, Foster, Davis, & Menaker, 1990). 
Moreover, Guo and colleagues (2006) found that SCN transplants from wild-type 
hamsters were also able to restore circadian rhythmicity in tau mutants, which are 
normally arrhythmic. It is also interesting to note that each SCN neuron is able to 
independently generate its own circadian rhythm when removed from the SCN (Liu & 
Reppert, 2000; Welsh, Logothetis, Meister, & Reppert, 1995), yet within the intact SCN 
neurons couple to form strong synchronized circadian rhythms such as metabolic activity 
(Schwartz & Zimmerman, 1991) and gene expression (Hastings & Herzog, 2004; Reppert 
& Weaver, 2002). 
Photic (light) information enters the retina and is transmitted via the 
retinohypothalamic tract (RHT; Panda & Hogenesch, 2004), which is distinct from the 
pathway involved in the interpretation of visual stimuli, directly to the SCN (Berson, 
Dunn, & Takao, 2002). While photic information affects the SCN the most (Wakamatsu 
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et al., 2001), it is also true that a number of non-photic cues such as one's health 
(Hastings, Reddy, & Maywood, 2003), social interactions (Roenneberg, Kumar, & 
Merrow, 2007), feeding schedules (Verwey, Khoja, Stewart, & Amir, 2007), and 
olfactory cues (Amir, Cain, Sullivan, Robinson, & Stewart, 1999) have been found to 
also have a significant impact on the circadian system. However, these cues affect 
mostly molecular oscillators located in brain regions other than the SCN (Abe et al., 
2002). 
Feedback loops and clock genes 
The SCN regulates and coordinates overt behavioral and physiological rhythms in 
the brain and peripheral tissues (Peirson et al., 2006). All circadian rhythms appear to 
arise from the interaction of a small set of core clock genes which make up the molecular 
clockwork (Ko & Takahashi, 2006; Lowrey & Takahashi, 2004). Circadian clocks 
express an autonomous oscillator which features positive and negative feedback loops 
that can be entrained to environmental synchronizers via various input pathways in order 
to give rise to overt rhythms. The main clock genes involved in this oscillatory system 
include Clock and Bmall, comprising the positive arm, and Cryptocrome (Cryl, Cry2) 
and Period (Perl, Per 2, Per 3), comprising the negative arm of the feedback loop (Ko & 
Takahashi, 2006; Reppert & Weaver, 2002). Clock genes and their respective feedback 
loops are not solely expressed in the SCN; in fact, they are found in many other tissues 
and organs throughout the body (Glossop & Hardin, 2002). However, SCN-lesioning 
experiments have shown that although various organs such as the lungs and the liver still 
exhibit circadian rhythms in gene expression, acute arrythrnicity occurs once these 
peripheral oscillators are deprived of outputs from the SCN for several cycles (Yamazaki 
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et al., 2000). These findings support the idea that the SCN's main role is to maintain the 
rhythms of self-sustained cellular oscillators both in the brain and in the periphery. 
Most experiments investigating the mechanisms generating circadian oscillation 
at the molecular level have been conducted with peripheral tissue because of the ease of 
access and the large amount of tissue available. Certain types of cells, such as liver cells 
(Reddy & May wood, 2007; Reppert & Weaver, 2002), islets of Langerhans cells 
(Allaman-Pillet et al., 2004; Muhlbauer, Wolgast, Finckh, Peschke, & Peschke, 2004) or 
exocrine cells from the pancreas (Kramer & Poort, 1971) for instance, have rapid division 
rates making them excellent candidates for in vitro studies. While these studies are 
invaluable when trying to pinpoint the function of certain circadian oscillators, it is only 
by also being able to conduct these studies in vivo, that one can drive more complete 
conclusions of the exact function of these oscillators. After all, only when looking at the 
entire organism, is it possible to understand the multitude of interacting feedback loops 
from the various tissues and organs, which may interact with outputs from the SCN. 
From a phylogenic point of view, the Per genes are thought to be the most rapidly 
evolving genes regulating circadian oscillators (Tauber et al., 2004). Given the fact that 
they are also among the genes that affect circadian oscillations the most, it is not 
surprising to see that such a vast part of the circadian literature has been focusing on 
understanding their function (Lowrey & Takahashi, 2000; Reppert & Weaver, 2002). 
Mutant experiments 
Mutant Per2 experiments have found that mice without Per2 function have 
transient rhythms with a shortened period of 22 hr (Zheng et al., 1999). While 
considering a different allele of the Per2 gene, Bae and colleagues (2001) even reported 
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complete arrythmicity in Per 2 mutant mice placed in a normal light/dark (LD) cycle. 
Furthermore, most mutant mice lose rhythmicity when placed in constant darkness 
(Zheng et al., 2001). One should also note that Perl and Per2 double mutants exhibit 
complete loss of their circadian rhythms (Albrecht, Zheng, Larkin, Sun, & Lee, 2001; 
Zheng et al., 1999). Despite the fact that mutant Perl and Per2 mice are morphologically 
indistinguishable from their wild-type counter-parts, suggesting that these genes are not 
essential for proper cell differentiation during development, these animals display various 
symptoms of premature aging: more rapid decline in fertility, loss of soft tissues, 
development of kyphosis, hyperplasia of the salivary glands (Lee, 2006; Lowrey & 
Takahashi, 2000), and a slight increase in the number of cancerous tumors (Granda et al , 
2005). Due to the fact that Per2 mutants seem to experience such a wide range of 
symptoms, a more specific method of targeting Per2 is needed if one is to study its 
impact on circadian rhythms exclusively. While one can observe severe disruption of 
circadian rhythms in Per2 mutants, one cannot entirely exclude the potentially additive 
disruptive effects due in part to the development of kyphosis, an arching of the back 
which can slightly reduce mobility, on locomotor activity. Due to these and other 
confounds there is little concrete evidence for a direct link between Per2 expression in 
the SCN and the disruption of circadian rhythms in behavior. 
Gene silencing with antisense oligonucleotides 
In order to link Per2 expression in the SCN to circadian rhythms, one requires 
local silencing of the gene and this can be achieved through the use of antisense ODNs 
(Wakamatsu et al., 2001). These are short single-stranded (typically 19 to 25 base-pair-
long) molecules which are complementary to specific messenger RNA (mRNA) 
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sequences. During transcription, mRNAs are formed from a DNA strand as various 
enzymes, such as RNA polymerase, copy the genetic code of specific genes. 
Subsequently, the mature mRNA leaves the cell nucleus and is expelled into the 
cytoplasm. It is then intercepted by ribosomes which attach to it and subsequently trigger 
translation of the genetic code contained within the single-stranded mRNA into the 
various proteins it codes for (Fire, 1999). At the same time, transfer RNA (tRNA) 
supplies the ribosomes with the required amino acids to constitute new proteins. 
However, if one were to inject antisense ODNs in the neighboring region of a cell, the 
antisense would be able to pass across the cellular membrane's pores and penetrate into 
the cytoplasm. There, the antisense has a high affinity to bind with its complementary 
base pairs located on mRNA strands. Once it detects a suitable piece of mRNA, the 
antisense attaches to it. Ribosomes are unable to translate double-stranded mRNA and 
thus the proteins for which the mRNA is coding for will not be formed. As a result, one 
is able to inhibit protein synthesis by injecting antisense ODNs into the surrounding 
tissue of a region of interest. The disadvantages of this technique are threefold: 1) It has 
been reported that in some cases only seven nucleotides binding to the proper 
complimentary mRNA strand suffice to halt translation (Fire et al., 1998). Hence, one 
can shut down the synthesis of multiple proteins which have partial complimentarity to 
the ODN used. Animal studies have shown that this can have potentially lethal side 
effects ranging from decreased heart rate to significant drops in white blood cell counts 
(Dias & Stein, 2002). 2) ODNs attach to the mRNA through the formation of hydrogen 
bonds, however, given the shortness of each antisense strand, not many bonds form and 
as a result the suppression effect is only short lasting as various enzymes, known as 
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RNases, degrade the hydrogen bonds (Dias & Stein, 2002). Once the hydrogen bonds are 
broken, ribosomes are again able to attach to the now single-stranded mRNA and 
recommence protein synthesis. 3) Each ODN is only able to bind to one mRNA strand 
and is generally degraded in a few hours (Choleris et al., 2007). Therefore, repeated 
injections with high concentrations are required in order to have a longer lasting and 
more potent effect. By increasing the concentrations however, one also increases the 
likelihood of cytotoxicity and off-target effects (Fire et al., 1998). 
RNA interference 
Another method of silencing genes is through the use of double-stranded RNA 
(dsRNA) to activate what is now termed the RNA interference (RNAi) pathway. There 
are two sub-types of RNAi: 1) Post-transcriptional gene silencing (PTGS) in which 
transcription of the target locus is unaffected but the half-life of the target RNA is 
significantly decreased (Montgomery, Xu, & Fire, 1998). 2) Transcriptional gene 
silencing (TGS) in which the structure of the chromatin template which forms the DNA 
strands is modified (Matzke et al., 1989). The latter is usually longer lasting than the 
former because RNA polymerase is unable to commence transcription. Therefore, if one 
is interested in silencing a given gene only for a few days, it is preferred to use PTGS by 
injecting long dsRNA. 
Most long dsRNA are processed into short interference RNA (siRNA) rather 
effectively by an RNase-like enzyme named Dicer; however, dsRNA can induce a non-
specific interferon response in mammalian cells when it is injected in large quantities 
(Minks, West, Denvin, & Baglioni, 1979; Pestka & Langer, 1987). Dicer recognizes 
dsRNA as it penetrates the cytoplasm and cleaves it into small siRNA fragments 
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(Dykxhoorn, Novina, & Sharp 2003). Other enzymes, such as Argonaute bind to the 
siRNAs and form the RNA-induced silencing complex (RISC), a catalytic complex 
responsible for target mRNA cleavage (Schwarz et al., 2003). Each RISC contains only 
one of the two strands of the siRNA; some suggest that both strands are able to 
successfully induce RNAi if they are able to find an appropriate target (Martinez, 
Patkaniowska, Urlaub, Luhrmann, & Tuschl, 2002), while others maintain that only the 
antisense strand which is less tightly paired to its complement, is incorporated into RISC 
while the other is degraded (Schwarz et al , 2003). Either way, RNAi through the use of 
long dsRNA is an effective method of transiently suppressing gene expression in a given 
structure for several days (Bhargava, Dallman, Pearce, & Choi, 2004). 
Rationale and objectives 
Although it has been shown that direct suppression of Per 2 gene expression in the 
SCN with antisense ODNs disrupts regular function of the clock (Sugiyama et al., 2004), 
the effect of suppression of Per 2 in the SCN on behavioral rhythms is unknown. In order 
to attempt to clarify the role of Per2 in the SCN on locomotor activity and PER2 
expression in SCN-targeted structures such as the CEA, BNST-ov and DG, I performed 
bilateral injections of dsRNA to Per2 into the SCN of male rats. 
In experiment 1, rats were placed in constant darkness after bilateral SCN 
microinjections of long dsRNA to Per2 in order to assess the effects of transient gene 
suppression on locomotor activity. Experiment 2 investigated the masking effect of light 
on PER2 expression in the SCN and limbic forebrain. This was achieved by placing rats, 
following surgery, back under the same LD cycle they were previously entrained to. 
Finally, experiment 3 looked at the specificity of the long dsRNA to Per2 used, by 
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labeling alternate brain sections for PER2 and cFos immunoreactivity. Unlike PER2 
(Beaule, Houle, & Amir, 2003) or cFos expression in the shell of the SCN (SCN-sh; 
Beaule, Arvanitogiannis, & Amir, 2001), cFos expression in the core of the SCN (SCN-
co) is regulated by entraining light (Beaule & Amir, 1999). Therefore, cFos 
immunoreactive nuclei were counted separately in the SCN-sh and SCN-co. 
Method 
Subjects 
Adult male Wistar rats (Charles River Laboratories, St-Constant, QC) weighing 
between 315 gm and 425 gm on the day of surgery were used in these experiments. The 
rats were housed individually in clear plastic cages (50 cm X 27 cm X 37 cm) which 
were equipped with running wheels. The rats had ad libitum access to food and water 
during the entire experiment. The room in which the animals were housed was 
maintained at approximately 21 °C throughout the testing period. All procedures were in 
accordance with the Canadian Council on Animal Care guidelines and were approved by 
the Animal Care Committee at Concordia University. 
Apparatus 
All cages were individually housed within sound- and light-proof enclosures (66 
cm X 66 cm X 44 cm). Each enclosure contained a fluorescent light source (outputting ~ 
300 lux), which was computer-controlled using VitalView (MiniMitter Co. Inc., 
Sunriver, OR), as well as a ventilation system to ensure proper airflow. Running-wheel 
activity was recorded using a magnetic switch connected to the VitalView system. 
Actograms were generated using Actiview (vl.2, MiniMitter Co. Inc., Sunriver, OR) and 
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the data were subsequently analyzed using Circadia Software (Behavioral Cybernetics, 
Cambridge, MA) in order to display and analyze running-wheel activity levels throughout 
the experiments. 
Procedure 
Each rat was entrained to a 12:12 hr LD cycle for at least 10 days before any 
manipulation took place. Throughout this period, locomotor activity was measured. This 
served a dual purpose: It provided a baseline activity level for all animals while at the 
same time serving as a measure of light entrainment for each individual. Rats were 
randomly divided into 2 groups: The experimental group received bilateral long double-
stranded RNA (dsRNA) to Per2 injections (6 ug in a volume of 1.5 ul per side) into the 
SCN, while the control group received bilateral injections of B-globin dsRNA (1.5 ul per 
side) into the SCN. After surgery, the rats were placed back into their respective home 
cages. In experiment 1, rats (n = 16) were placed back in constant darkness for 46 days 
while their activity levels were recorded. A second group of rats (n = 6) were placed in 
constant dark for 21 days. Afterwards, they were placed under a 12:12 hr LD cycle 
which was the reverse of the one which they had initially been entrained to. In 
experiment 2, rats {n = 24) were placed back in the same LD cycle and were perfused 
three, six or 12 days after dsRNA microinfusions. A second group (n = 2) was bilaterally 
infused with dsRNA 1.5 mm dorsal to the SCN. Finally, in experiment 3, rats (n = 16) 
were entrained to a 12:12 hr LD cycle for 10 days. Afterwards, eight rats were bilaterally 
injected with dsRNA to Per2 and perfused six days later while the others were given 
placebo injections. Half of the rats of either group were perfused at ZT1 while the others 
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were perfused at ZT13. Alternate slices were stained for cFos and PER2 in order to test 
the specificity of the long dsRNA used in the present 
experiments. 
dsRNA synthesis 
Long dsRNA specific for Per2 was amplified by reverse transcription polymerase 
chain reaction and cloned in TopoII vector (Invitrogen, Burlington, ON) by Dr. Aditi 
Bhargava and her research team at the University of California, San Francisco. The 
resulting dsRNA was then placed in eppendorf tubes containing 6 (j,g of lyophilized 
dsRNA each. 
dsRNA reconstitution 
Each eppendorf tube containing 6 ug of lyophilized dsRNA was reconstituted by 
adding 1 ul of RNase-free water. The tubes were let to sit at room temperature for 15 
min after vortexing for 15 s and briefly centrifuging the mixture. Subsequently, 0.5 ul of 
Lipofectamine (Invitrogen) was added to each tube, followed by a brief 5 s of vortexing 
and centrifuging. Finally, the mixture was let to incubate at room temperature for 30 min 
before being ready to be injected into the SCN. 
Surgery and injections 
The rats were deeply anesthetized with a solution of ketamine/xylazine with 
concentrations of 100 mg/ml and 20 mg/ml respectively, administered intraperitoneally 
(0.15 ml/100 gm). Once anesthetized, the rats were securely fitted into a stereotaxic 
apparatus (Stoelting, Wood Dale, IL). The surface of the scalp was disinfected with 
iodine and a 1.5 cm long incision was made at the center of the skull. Two small holes 
were drilled at the appropriate coordinates from bregma for the SCN: anterior/posterior, -
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1.2 mm; and medial/lateral, ± 1.8 mm. Two Hamilton 2.0 ul syringes were loaded with 
1.5 ul dsRNA each and using the stereotaxic, two specially-designed needle tips were 
slowly lowered to - 8.3 mm below dura at a 10 ° angle in order to avoid hitting the 
sinuses. Once the proper depth was reached, the dsRNA was bilaterally injected over a 
10 min interval using an infusion pump (Harvard Apparatus, Holliston, MA). 
Afterwards, an additional 2 min interval was given in order to allow the surrounding 
tissue to completely absorb any remaining dsRNA. The needles were then retracted and 
the holes in the skull were filled with sterile bone wax and subsequently covered with a 
layer of sticky wax. Hibitane (Bioglan), an antifungal and antiseptic cream, was then 
applied locally in order to prevent infection and the lesion was sutured. The rats were 
then given a 0.15 ml (0.075 ml in each leg) intramuscular injection of Procilin (MTC 
Bimeda, Cambridge, ON), an antibiotic and analgesic. Finally, each rat received a 2.0 ml 
(1.0 ml per side) subcutaneous injection of saline 0.9 % in order to facilitate re-hydration. 
After awaking, each rat was taken back to its home cage where it remained for the rest of 
the experiment. 
Perfusions 
The rats were deeply anesthetized with an overdose of sodium pentobarbital (~ 
100 mg/kg, Somnotol, MTC Bimeda) administered intraperitoneally and perfused intra-
cardially with 300 ml of cold saline solution (0.9 % NaCl), followed by 300 ml of cold 4 
% paraformaldehyde in a 0.1 M phosphate buffer (pH 7.3). Subsequently, the brains 
were post-fixed for 24 hr in 4 % paraformaldehyde at 4 °C. The following day, the brains 
were sliced using a vibratome (Vibratome, St-Louis, MO) into 50 um thick coronal 
sections while being placed in cold trizma buffered saline (TBS). After a series of three 
13 
10 min TBS rinses to remove any remaining traces of paraformaldehyde, the sections 
were transferred into Watson's cryoprotectant and maintained at -20 °C until 
immunocytochemistry was performed. 
Immunocytochemistry 
Brain sections were taken out of Watson's cryoprotectant and rinsed in six 10 min 
cold TBS washes to remove any excess cryoprotectant. Brain sections were then 
transferred into quenching solution, consisting of 90 % TBS and 10 % hydrogen peroxide 
(H2O2) for 30 min at room temperature. Three 10 min rinses in cold TBS followed. 
Sections were then transferred into pre-block solution (0.3 % Triton X in TBS and 5.0 % 
normal goat serum) for 1 hr at 4 °C. Sections were transferred directly into a primary 
antibody solution, consisting of rabbit polyclonal antibody raised against PER2 diluted to 
1:2000 in Triton X-100 in TBS and normal goat serum (NGS), where they were 
incubated for 48 hr at 4 °C. Sections were rinsed for three times 10 min in cold TBS. 
Brain sections were incubated in a secondary antibody solution, constituted of 
biotinylated anti-rabbit IgG made in goat (Vector Laboratories, Burlington, ON) diluted 
1:200 in Triton TBS and 3 % NGS, for 1 hr at 4 °C. Another three 10 min rinses in cold 
TBS followed. The sections were then transferred into ABC solution (avidin-biotin-
peroxidase complex) in TBS for 2 hr at 4 °C (Vectastain Elite ABC Kit, Vector 
Laboratories). Sections were then rinsed for three 10 min periods in cold TBS followed 
by an additional 10 min rinse with cold 50 mM Tris-HCL. Afterwards, sections were 
incubated for 10 min in 0.05 % diaminobenzidine (DAB) in Tris-HCL. Following this 
step, sections were incubated for 10 min in DAB diluted in 50 mM Tris-HCL with 0.01 
% H2O2 and 8 % Nickel Chloride (NiCb). Finally, the sections were rinsed with cold 
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TBS for three times 10 min and then mounted on gel-coated slides the following day. 
The next day, slides were dehydrated in alcohols of various concentrations for 10 min 
each, soaked in Citrosolve (Fischer Scientific, Houston, TX) for at least 30 min and 
coverslipped with Permount (Fischer Scientific). 
Data analysis 
Behavior 
Actograms generated by the VitalView monitoring system were visually analyzed 
in order to ascertain entrainment and locomotor activity. 
Brain 
The coverslipped slides were inspected under a light microscope (Leitz Laborlux 
S) and images of the SCN, CEA, the BNSTov and DG were captured using a Sony XC-
77 video camera connected to a Scion LG-3 frame grabber using NIH Image software 
(vl.63). Bilateral images were captured at 20X magnification using a 400 X 400 um 
template. Cells which were immunoreactive for PER2 were counted using Image SXM 
software (vl.79) in all experiments. The average of the 6 sections containing the highest 
numbers of labeled nuclei was used to calculate the final immunoreactivity of each area 
in each subject. The same procedure was used to count cFos immunoreactivity in 
experiment 3. 
Experiment 1 
Rats were first placed on a 12:12 hr LD cycle for two weeks. In order to observe 
the effect of long dsRNA to Per2 on overall locomotor activity and any potential shifts in 
free running rhythms, rats were then placed in constant darkness for 46 days following 
bilateral dsRNA infusions, while their activity levels were recorded. Rats were perfused 
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at circadian time (CT) 1, which corresponds to 1 hr after the subjective activity offset. A 
separate group of rats were placed in constant dark for 21 days. Afterwards, they were 
placed under a 12:12 hr reversed LD cycle for 14 days in order to ascertain that the SCN 
was still responsive to photic cues. Animals were then perfused at ZT1, 1 hr after activity 
offset (lights on). 
Experiment 2 
To examine the effect of long dsRNA to Per2 on locomotor activity and in order 
to measure the degree of silencing as well as the length of PER2 suppression, rats were 
perfused at ZT13 (1 hr after activity onset) three, six and 12 days after bilateral dsRNA 
infusions in the SCN while activity levels were monitored throughout. The masking 
effect of light on the SCN was tested by placing the rats back under the same LD cycle 
following surgery. The resulting differences in counts of immunoreactive cell nuclei for 
PER2 were analyzed using a 2-way ANOVA with days (three, six or 12) and treatment 
(experimental or control) as the independent variables. The alpha level was set at .05 for 
all analyses. A second group was bilaterally infused with dsRNA 1.5 mm dorsal to the 
SCN in order to test whether locomotor disruption and PER2 suppression was not due to 
spreading of the dsRNA up the injection tract. 
Experiment 3 
In order to determine whether the long dsRNA to Per2 was in fact as specific as 
believed and that it was not also suppressing the expression of other genes, PER2 and 
cFos immunoreactivity was assessed in alternate sections in rats perfused at ZT1 or 
ZT13, six days after microinfusions. The resulting differences in counts were analyzed 
using a 2-way ANOVA with perfusion time (ZT1 and ZT13) and treatment (experimental 
16 
or control) as the independent variables for PER2 and cFos. All analyses were evaluated 
for significance at a = .05. 
Results 
Experiment 1 
Behavior in constant darkness 
After being initially placed on a 12:12 hr LD cycle for 14 days, 20 rats were 
placed in constant darkness while their running wheel activity was measured every 10 
min. Initially, locomotor activity was relatively random; however, all rats became 
entrained in a matter of days. The criterion for entrainment was defined as a pattern of 
running wheel activity which was almost exclusively limited to the dark phase. Two 
weeks post-entrainment rats were anesthetized and bilaterally infused with dsRNA to 
Perl (n= 16) or P-globin 
{n = 4; shown by the arrow in each one of the double-plotted actograms in Figure 1). 
Rats were then placed back in their home cages under constant darkness in order to assess 
the effect of dsRNA on free running activity. Four of the 16 experimental rats were 
excluded due to unilateral or bilateral dsRNA infusion misses. As can be seen in the 
sample actograms (Figure 1 A), experimental rats showed an arrhythmic running pattern 
up to 8 days post-surgery. Conversely, control rats (Figure IB) exhibited disruption in 
their running patterns for the first two days after surgery only; a period of time 
corresponding with the time needed for recovery. Thus, on the third day post-surgery, 
control rats were active during their usual endogenous dark period whereas the 
experimental rats were entirely arrhythmic. Activity levels were monitored up to 46 days 
17 
dsRNA dsRNA p Control 
Figure 1. Representative double-plotted (48 hr) actograms showing wheel running 
activity rhythms before and after bilateral intra-SCN infusions of (A) long dsRNA to 
Per2 or (B) control solution (P-globin). The day of infusion is marked with an arrow. 
Rats were initially entrained to a 12:12 hr LD cycle and then returned to constant 
darkness following SCN infusions. White actogram portions indicate lights on while grey 
actogram portions indicate lights off. Black marks show periods of activity of at least 10 
wheel rotations/10 min. Successive days are plotted from top to bottom. 
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following surgery before all rats were sacrificed. 
Constant darkness and light/dark cycle reversal 
Six additional rats (experimental: n = 3; control: n - 3) were subject to the same 
experimental conditions as described above except that following surgery, rats were 
placed in constant darkness for 21 days and then exposed to a reverse 12:12 hr LD cycle 
for 14 days before being sacrificed. As shown in Figure 2, all rats were fully entrained 
within the first 2 days following exposure to the new LD cycle. This indicates that 
dsRNA did not have any long-lasting secondary side effects on the experimental rats' 
ability to entrain to a novel LD cycle. 
Experiment 2 
Behavior 
As in experiment 1, rats were placed on a 12:12 hr LD cycle for 14 days. After 
bilateral infusions of dsRNA to Per2 or |3-globin, rats were placed back in home cages 
and kept on the same lighting schedule for the remainder of the experiment. Rats were 
then perfused at ZT13, three days (experimental: n = 4; control: n = 4), six days 
(experimental: n — 4; control: n = 4) and 12 days (experimental: n — 4; control: n = 4) 
after surgery. Figure 3 shows sample double-plotted actograms of each one of the three 
perfusion days, both for the experimental (A) and control rats (B). Upon inspection of 
Figure 3 it is apparent that experimental rats remained arrhythmic, to some degree, for up 
to eight days post-surgery. Interestingly the rats in this experiment showed less 
arrhythmicity than rats in experiment 1. This may be due to the masking effect of light 




 R Control 
Figure 2. Representative double-plotted actograms showing wheel running activity 
rhythms before and after bilateral intra-SCN infusions as well as post-infusion light 
entrainment. (A) long dsRNA to Per2 or (B) control solution (p-globin) were infused on 
the day marked with the arrow. Rats were entrained to a 12:12 hr LD cycle for 14 days 
and then released into constant darkness for 21 days following SCN infusions. Rats were 
then placed on a reverse 12:12 hr LD cycle in order to assess whether the SCN neurons 
could still entrain to light. White portions of the actogram indicate lights on while the 
grey portions indicates lights off. Black marks show periods of activity of at least 10 
wheel rotations/10 min. Successive days are plotted from top to bottom. 
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Figure 3. Double-plotted actograms showing wheel running activity in rats perfused at 
ZT13, three, six or 12 days after bilateral intra-SCN infusions of (A) dsRNA to Per 2 or 




All rats were perfused at ZT13 in order to measure the rate of suppression of 
PER2 expression in experimental animals. Figure 4 provides sample photomicrographs 
which correspond to the respective actograms found in Figure 3. Mirroring the recovery 
of rhythrnicity previously demonstrated in Figure 3 a recovery in the number of PER2 
immunoreactive (PER2-ir) nuclei was apparent as time post-surgery increased for rats in 
the experimental condition (Figure 4A). Further analyses of these data show significantly 
less PER2-ir in experimental rats when compared to controls, F(\, 18) = 43.04,p < .01, 
n = .71. This suppression of PER2-ir was significant at all time points (Day 3: F(l, 6) = 
42.60,/? < .01, n2 = .88; Day 6: F(l, 6) = 6.79,/? < .05, n2 = .53; Day 12: F(l, 6) = 10.90, 
p < .05, n = .65) suggesting that dsRNA to Per2 did successfully suppress PER2 
expression in the SCN. This suppression appeared transient in nature as rats perfused 
three, six and 12 days after surgery had a mean PER2-ir suppression, relative to control 
rats, of 59 %, 39 % and 26 % respectively (Figure 5A). 
BNST-ov 
Figure 5B shows the mean expression of PER2-ir nuclei in the BNST-ov of rats 
perfused at ZT13, three, six and 12 days after bilateral microinfusions of dsRNA to Per2 
into the SCN. Here a significant effect of perfusion day, F(2, 18) = 5.26, p < .05, n = 
.37, and experimental treatment, F(l, 18) = 131.05,/? < .01, r\2 - .88, was evident. Upon 
further investigation dsRNA was shown to significantly suppress PER2-ir on all 
perfusion days (Day 3: F(\, 6) = 43.05,/? < .01, n2 = .88; Day 6: F(l, 6) = 39.40,/? < .01, 
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Figure 4. Photomicrographs showing examples of PER2 immunoreactivity in the SCN 
(unilaterally) in rats killed at ZT13, three, six or 12 days after intra-SCN infusions of (A) 
dsRNA to Perl or (B) control solution (p-globin). These photomicrographs correspond to 
























































Figure 5. PER2 immunoreactive nuclei (Means ± SE) in the (A) SCN and (B) BNST-ov 
in rats killed at ZT13 three (n = 8), six (n = 8) or 12 days (n = 8), after bilateral intra-SCN 
infusions of dsRNA to Perl (white bars) or control solution (P-globin; gray bars). Black 
regions on the brain maps indicate relative locations of the areas under investigation. 
*j9<.05. **/?< .01. 
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greater in the experimental rats on day 12, as compared to day 3, t(6) = -3.52,p < .05. 
CEA 
Figure 6A shows the mean expression of PER2-ir nuclei in the CEA of 
experimental and control rats perfused at ZT13, three, six and 12 days after bilateral 
microinfusions of dsRNA to Per 2 into the SCN. A between subjects ANOVA revealed a 
significant main effect of perfusion day, F(2, 18) = 5.1 \,p < .05, n = -36, as well as a 
significant main effect of treatment, F{\, 18) = 55Al,p < .01, n = .75. However, there 
was no significant interaction between treatment and time of perfusion. Further analysis 
revealed a suppression of PER2-ir in the experimental group on all perfusion days (Day 
3: F(l, 6) = 25.83,/? < .01, n2 = .81; Day 6: F(l, 6) = 21.30,/? < .01,
 n
2
 = .78; Day 12: 
F{\, 6) = 8.84,/? < .05, r|2 = -60). However, a significant recovery of PER2 expression in 
the experimental rats was observed between day 3 and day 12, t{6) = -4.62,/? < .01. 
DG 
Figure 6B shows the mean expression of PER2-ir nuclei in the DG of 
experimental and control rats perfused at ZT13, three, six and 12 days after bilateral 
microinfusions of dsRNA to Per2 into the SCN. A between subjects ANOVA revealed a 
main effect of treatment, F(l, 18) = 37.87,/? < .01, rf = .68, but no significant effect of 
perfusion day or treatment by perfusion day interaction. Contrary to findings in the 
BNST-ov and the CEA experimental rats showed increased PER2-ir in the DG relative to 
control rats. Further analyses were performed in order to assess the effect of SCN 
dsRNA infusion over time. These analyses revealed a significant difference between 
•y 
experimental and control rats on all perfusion days (Day 3: F(\, 6) = 23.32,/? < .01, n = 

















































Figure 6. Mean number of PER2 immunoreactive nuclei (± SE) in the (A) CEA and (B) 
DG in rats killed at ZT13 three (n = 8), six (n = 8) or 12 days (n = 8), after bilateral intra-
SCN infusions of dsRNA to Per2 (white bars) or control solution (P-globin; gray bars). 
Black regions on the brain maps indicate relative locations of the areas under 
investigation. 
* jp<.05. **p<.01. 
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The DG did show some recovery of PER2 rhythmicity, t{6) = 2.56, p < .05, contrary to 
the other brain regions which were investigated. 
Dorsal controls 
In order to verify the specificity of dsRNA two rats were bilaterally infused with 
dsRNA to Per2 1.5 mm dorsally to the SCN. Figure 7 displays the actograms of these 
two rats when entrained to a 12:12 hr LD cycle for 14 days prior to surgery and 6 days 
post-surgery. These actograms are virtually identical to those of rats having received P-
globin control injections, suggesting that dsRNA to Per2 disrupts circadian function 
through a direct effect on the SCN. 
Experiment 3 
Behavior 
Running wheel activity was monitored throughout the course of the experiment. 
The resulting actograms were exact replications of the findings in experiment 2 (data not 
shown). Rats were perfused either at ZT1 or ZT13, six days after surgery. 
PER2 immunocytochemistry 
SCN 
Figure 8 shows representative photomicrographs from the SCN of rats which 
were bilaterally infused with (A) dsRNA to Per2 in the SCN at ZT1 and ZT13, and of 
rats bilaterally infused with (B) P-globin in the SCN at ZT1 and ZT13. A between 
subjects ANOVA revealed a significant main effect of perfusion time, F{\, 12) = 71.30, 
p < .01, n2 = .86, treatment group, F(l, 12) = 4.79, p < .05, r\2 = .29, and a perfusion time 
by treatment interaction, F(l, 12) = 24.43, p < .01, n2 = .67. Overall PER2-ir was greater 
at ZT13. However, at ZT1 rats in the experimental group displayed significantly more 
27 
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Figure 7. Double-plotted actograms showing wheel running activity in dorsal control rats 
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Figure 8. Photomicrographs showing examples of PER2 immunoreactivity in the SCN 
(unilaterally) in rats killed at ZT1 and ZT13, six days after intra-SCN infusions of (A) 
dsRNA to Per2 or (B) control solution (P-globin). 
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PER2-ir than rats in the control group, (^6) = 5.04, p < .01 (Figure 9A). 
Limbic Forebrain Regions 
The mean PER2-ir nuclei at ZT1 and ZT13, for rats perfused six days after 
surgery is displayed in Figure 9. For both the BNST-ov (B) and the CEA (C) rats 
displayed significantly more PER2-ir at ZT13 than ZT1, FBNST-OVQ, 12) = 38.46,/? < .01, 
H2 = .76; FCEA(1, 12) = 59.14,/? < .01, n2 = .83 . Moreover, a significant effect of 
treatment was also observed. BNST-ov and CEA PER2-ir was significantly reduced in 
the dsRNA group, FBNSr-oV(l, 12) - 5.47,p < .01, r\2 = .76; FCEA(U 12) = 26.97,p< .01, 
n2 = .69. Furthermore for the CEA a significant interaction between perfusion time and 
treatment was observed, F{\, 12) = 9.76, p < .01, n2 = -62. Investigation of this 
interaction revealed a significant suppression of PER2-ir in experimental rats at ZT13, 
(^6) = 6.23, p < .01. Similar to the BNST-ov and the CEA there was a significant effect 
of perfusion time, F(l, 12) = 93.75, p < .01, n2 = .89, and treatment, F(l, 12) = 15.89, 
p < .01, n2 = .57, when investigating DG PER2-ir. Moreover a significant interaction 
between time of perfusion and treatment was also observed, F(l, 12) = 30.25, p < .01, 
n2 = .72. However, contrary to findings in the BNST-ov and CEA a significant blunting 




Figure 10 shows representative photomicrographs of cFos-ir in the SCN of rats 
which were bilaterally infused with (A) dsRNA to Perl in the SCN at ZT1 and ZT13, 







































































Figure 9. PER2 immunoreactive nuclei (Means ± SE) in the (A) SCN, (B) BNST-ov, (C) 
CEA and (D) DG in rats sacrificed at ZT1 (n = 8) or ZT13 (n = 8), 6 days after bilateral 
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Figure 10. Photomicrographs showing examples of cFos immunoreactivity in the SCN 
(unilaterally) in rats killed at ZT1 and ZT13, six days after intra-SCN infusions of (A) 
dsRNA to Per2 or (B) control solution ((3-globin). 
32 
Figure 11A shows a schematic, drawn on top of a representative photomicrograph of 
cFos-ir in the SCN, depicting the separation that exists between the shell and the core. As 
seen in Figure 1 IB the mean expression of cFos-ir in the SCN-sh or SCN-co (Figure 
11C) was not significantly different for experimental and control rats. However, as 
demonstrated previously for PER2-ir, perfusion time did have a significant effect on 
cFos-ir in both the SCN-co, F(l, 12) = 157.90,/? < .01, n2 = .93 and SCN-sh, F(l, 12) = 
13.46,/? < .05, n = .53. In both regions cFos-ir was reduced at ZT13. 
Limbic Forebrain Regions 
Figure 12 shows the mean expression of cFos-ir in the BNST-ov (A), CEA (B) 
and DG (C) of experimental and control rats perfused at ZT1 or ZT13, six days following 
bilateral microinfusions of dsRNA to Per 2 into the SCN. In all regions a significant main 
effect of perfusion time was observed (FENST-OVO, 12) = 157.90,/) < .01, n = .93; FCEA(}, 
12) = 25.13,/? < .01, n2 = .68; FDG{\, 12) = 19.67,/? < .01, n2 = .62); however, there were 
no significant main effects of treatment and no significant interactions. Furthermore, in 
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Figure 11. (A) Sample photomicrograph showing cFos expression as well as a schematic 
of the two sub-sections of the SCN: the shell and the core, indicated by the arrows. cFos 
immunoreactive nuclei (Means ± SE) in the (B) SCN shell and (C) SCN core in rats 
sacrificed at ZT1 in = 8) or ZT13 (n = 8), six days after bilateral intra-SCN infusions of 
dsRNA to Per2 (white bars) or control solution (P-globin; gray bars). 




























































Figure 12. Mean number of cFos immunoreactive nuclei (± SE) in the (A) BNST-ov, (B) 
CEA and (C) DG in rats sacrificed at ZT1 (n = 8) or ZT13 (n = 8), six days after bilateral 




Mutant studies have suggested that PER2 plays a key role in the regulation of 
circadian rhythms in behavior (Spoelstra, Albrecht, van der Horst, Brauer, & Daan, 2004; 
Zheng et al., 1999). However, evidence for a direct link between circadian rhythms in 
behavior and PER2 expression in the SCN is lacking due to developmental confounds is 
mutants (Sumova et al., 2006; Zueger et al., 2006) and limitations associated with ODNs 
(Wakamatsu et al., 2001). In order to circumvent these confounds, the present thesis 
examined whether dsRNA to Perl, infused locally through bilateral infusions into the 
area of the SCN, could suppress both circadian wheel running and PER2 protein 
expression. These infusions produced a transient disruption in locomotor activity 
rhythms in rats housed on a 12:12 hr LD cycle and in constant darkness. Moreover, this 
disruption in rhythmicity was correlated with a reduction in PER2-ir in the SCN and 
various limbic forebrain regions. 
In experiment 1, it was found that bilateral SCN microinjections of long dsRNA 
to Perl were effective at disrupting PER2 rhythmicity in the SCN for up to eight days. 
The specificity of this effect was demonstrated by showing no effect of dsRNA when 
injected a few millimeters off-target (dorsal controls) or when a unilateral or bilateral 
injection was missed. 
The behavioral data show that rats can become entrained to a reverse LD cycle 
very rapidly after having been exposed to constant darkness for an extended period of 
time. Moreover, rats given bilateral dsRNA infusions into the SCN were able to entrain, 
as quickly as control rats given only a vehicle, to a reverse LD cycle after the eight days 
during which the dsRNA is effective. This demonstrates a transient effect of dsRNA 
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suppression. 
Experiment 2 investigated the masking effect of light on PER2 expression in the 
SCN and limbic forebrain. As expected, once experimental rats were placed post-surgery 
on a LD cycle, light masked part of their behavior and therefore, they seemed to be better 
entrained than the rats in experiment 1, running more during the dark phase. By 
perfusing the rats at ZT13, three, six and 12 days post-surgery and quantifying PER2-ir in 
the SCN, BNST-ov, CEA and DG, I was able to determine the course of the effectiveness 
of the dsRNA to Perl. It was found that PER2 was suppressed 59 %, 39 % and 26 % 
after, three, six and 12 days respectively. These findings further support the behavioral 
results showing that dsRNA is transient. These results also help us to better interpret 
some of the findings in experiment 1: Although experimental rats were arrhythmic in 
constant darkness for up to eight days, once they started free-running, their period 
corresponded almost perfectly to that of control rats, which had been free-running ever 
since the animals underwent surgery. This re-synchronization with the free-running 
periods of the controls can be explained by the fact that maximal PER2 suppression was 
only 59 %. Therefore, there were many SCN neurons which were still expressing PER2; 
since each individual SCN neuron is able to maintain its own rhythm (Reppert & Weaver, 
2002), these neurons were able to remain rhythmic while neighboring neurons had their 
activity suppressed. Once the neighboring neurons were able to express PER2 again, 
they were able to re-synchronize with the neurons that had not lost rhythmicity. Given 
that in order to increase the degree of PER2 suppression, one would require injecting 
larger quantities of dsRNA, which would ultimately become cytotoxic (Fire, 1999), one 
cannot completely suppress PER2 expression in the SCN by using this method. 
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The PER2-ir counts from experiment 2 combined with the behavioral data from 
experiments 1 and 2 illustrate that there is a threshold effect of PER2 suppression; at 
which point behavioral rhythmicity is lost. This threshold seems to be in the vicinity of 
39 % because at six days post-surgery, some rats are still arrhythmic while others start 
regaining rhythmicity. These findings support previous research concluding that various 
posttranscriptional and posttranslational mechanisms are in place, which can ultimately 
delay clock gene expression to various degrees throughout the day (Harms, Kivimae, 
Young, & Saez, 2004), thus resulting in a blunted rhythm. 
Finally, experiment 3 looked at the specificity of the long dsRNA to Per2 
sequence used, by labeling alternate brain sections for PER2 and cFos in rats perfused at 
ZT1 or ZT13. It was found that PER2 was significantly suppressed but cFos expression 
was unaltered. An interesting finding was the fact that while PER2 expression was 
suppressed at ZT13; it was actually significantly higher than in controls at ZT1. A 
possible interpretation would be that since there is a six-hour delay between peak Per2 
mRNA levels and PER2 expression (Harms et al., 2004; Takahashi, 2004), by disrupting 
the circadian clock through PER2 suppression, PER2 levels are reduced at ZT13. Due to 
this reduction, the feedback mechanisms no longer function normally and thus produce a 
smaller troth; hence PER2 expression at ZT1 results in being higher than in controls. 
A possible limitation of these experiments is the fact that the noted effect could be 
due to a shift in the usual phase of PER2 expression, which may be the result of 
posttranscriptional and/or posttranslational processes such as phosphorylation, 
ubiquitylation and protein degradation (Tamanini, Yagita, Okamura, & van der Horst, 
2005). However, if this were the case, then the dsRNA would have merely caused a shift 
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in locomotor activity because animals whose phases are shifted by being placed on a 
different LD cycle for instance, will exhibit a gradual shift in locomotor activity, as can 
be seen during the entrainment phase of these experiments. Yet no such shift occurred; 
instead, locomotor arrhythmicity has been noted. Nevertheless, perfusing more animals 
at two additional time points could provide a better understanding of this matter and 
might help clear the issue at hand. Another possible criticism regarding the present thesis 
can be made when considering recent findings by Fujimoto, Yagita, and Okamura (2006), 
who reported that PER2 expression was possible without previous expression of its 
mRNA. This suggests that the circadian machinery's feedback loops are more complex 
than initially thought, however, there is not enough data to verify this speculation. 
The current thesis has shown that long dsRNA to Per2 can be used to transiently 
suppress PER2 expression in the SCN in vivo. Furthermore, it was shown that this 
suppression resulted in loss of locomotor circadian rhythmicity. The specificity of the 
dsRNA used was tested by measuring the amount of cFos-ir in alternate brain slices, 
which led to the conclusion that the dsRNA was in fact specific to Per 2 because it did not 
alter cFos expression. Future studies could investigate the effects of dsRNA to Per2 
infused into the SCN at additional time points such as ZT7 and ZT19 in order to draw a 
clearer picture of circadian PER2 fluctuations. Additionally, it would be of interest to 
investigate the effects of dsRNA infusions directly into other structures such as the 
BNST-ov, CEA, DG and even the dorsal medial hypothalamus, which plays a key role in 
restricted feeding. Finally, dsRNA can be used to look at the role played by PER2 in 
specific structures and its effects on metabolism since a number of studies (Liu et al., 
2007; Wijnen et al., 2006) have already outlined the importance of clock genes therein. 
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APPENDIX A: Experiment 2 PER2 ANOVA Tables 
Table Al 
Descriptive Statistics 
Perfusion Treatment SCN BNST-ov CEA DG 
Day 3 dsRNA M 139.50 74.00 107.00 54.68 
SE 24.67 9.55 8.40 7.75 
(3-globin
 M 337.75 149.00 182.25 15.95 
SE 17.73 6.28 12.20 2.05 
Day 6 dsRNA M 194.50 76.25 116.00 45.35 
SE 46.19 10.70 14.71 7.12 
p-globin
 M 317.75 153.75 189.25 20.60 
SE 10.27 6.16 5.95 6.17 
Day 12 dsRNA M 229.50 108.50 158.00 32.40 
SE 20.74 2.25 7.18 3.92 
p-globin
 M 310.25 158.00 193.50 14.45 
SE 12.95 4.81 9.54 2.59 
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Table A2 
























Note. Value enclosed in parentheses represents mean square errors. 
**/?<.01. 
Table A3 
Analysis of Variance by Perfusion Day for PER2 Immunoreactivity in the SCN 
2 
Days Source df F H p 


























Note. Values enclosed in parentheses represent mean square errors. 
*p< .05 . **p<.0l. 
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Table A4 
























Note. Value enclosed in parentheses represents mean square errors. 
*p< .05 . **p< .01 . 
Table A5 
Analysis of Variance by Perfusion Day for PER2 Immunoreactivity in the BNST-ov 
2 
Days Source df F n p 


























Note. Values enclosed in parentheses represent mean square errors. 
**p< .01 . 
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Table A6 
























Note. Value enclosed in parentheses represents mean square errors. 
*p< .05 . **p<.0\. 
Table A7 
Analysis of Variance by Perfusion Day for PER2 Immunoreactivity in the CEA 
2 
Days Source df F n p 


























Note. Values enclosed in parentheses represent mean square errors. 
*p< .05 . **/?<.01. 
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Table A8 
























Note. Value enclosed in parentheses represents mean square errors. 
**p<m. 
Table A9 
Analysis of Variance by Perfusion Day for PER2 Immunoreactivity in the DG 
2 
Days Source df F H p 


























Note. Values enclosed in parentheses represent mean square errors. 
*p< .05 . **p<.0\. 
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APPENDIX B: Experiment 3 PER2 ANOVA Tables 
Table Bl 
Descriptive Statistics 
Perfusion Treatment SCN BNST-ov CEA DG 
ZTl dsRNA M 112.71 43.04 45.21 48.13 
SE 7.12 5.59 8.68 9.36 
B-globin M 65.25 46.75 50.63 98.5 
SE 6.17 3.73 3.16 3.69 
ZTl 3 dsRNA M 173.05 79.21 68.71 25.92 
SE 30.5 8.08 6.49 2.97 
B-globin M 295.96 114.79 138.5 17.88 
SE 13.01 12.15 9.07 1.67 
Table B2 
Analysis of Variance by Treatment for PER2 Immunoreactivity in the SCN 
2 Source df F H p 
~ZT 1 71.30** ^36 m 
Treatment (T) 1 4.79* .29 .05 
ZTXT 1 24.43** .67 .00 
Error 12 (1188.04) 
Note. Value enclosed in parentheses represents mean square errors. 
* p < . 0 5 . * * p < . 0 1 . 
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Table B3 
























Note. Value enclosed in parentheses represents mean square errors. 
*p< .05 . **p< .01 . 
Table B4 
























Note. Value enclosed in parentheses represents mean square errors. 
**p< .01 . 
Table B5 
Analysis of Variance by Treatment for PER2 Immunoreactivity in the DG 



















Note. Value enclosed in parentheses represents mean square errors. 
**p< .01 . 
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Table B6 
Simple Effects of Treatment on PER2 Immunoreactivity at ZT1 

























Note. Values enclosed in parentheses represent mean square errors. 
**p< .01 . 
Table B7 






























Note. Values enclosed in parentheses represent mean square errors. 
*p< .05 . **p<.0\. 
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Table B8 
Simple Effects of Perfusion Time on PER2 Immunoreactivityfor dsRNA 

























Note. Values enclosed in parentheses represent mean square errors. 
Table B9 
Simple Effects of Perfusion Time on PER2 Immunoreactivity for B-globin 

























Note. Values enclosed in parentheses represent mean square errors. 
**p<M. 
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APPENDIX C: Experiment 3 cFos ANOVA Tables 
Table CI 
Descriptive Statistics 
Perfusion Treatment SCN-sh SCN-co BNST-ov CEA DG 
ZT1 dsRNA M 98.92 149.54 30.46 40.92 4.34 




























6-globin M 91.63 46.79 21.63 21.75 2.42 
SE 5.26 5.88 2.89 2.92 0.33 
Table C2 
























Note. Value enclosed in parentheses represents mean square errors. 
**p< .01 . 
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Table C3 
























Note. Value enclosed in parentheses represents mean square errors. 
** p<.0\. 
Table C4 
























Note. Value enclosed in parentheses represents mean square errors. 
*p< .05 . 
Table C5 
























Note. Value enclosed in parentheses represents mean square errors. 
**p< .01 . 
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Table C6 
























Note. Value enclosed in parentheses represents mean square errors. 
**p<m. 
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